Asceneuron will participate in the 22nd Annual Biotech in Europe Forum for global partnering and investment (BEF), being held on September 21st-22nd, 2022 in Basel.
The global bio-pharma industry event will address through its programme the main challenges in investment for 2022, partnering and alliance management and prospects for 2023. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors.
Our CEO Dirk Beher will take part in the panel discussion “CNS: Focus on Neurodegenerative Diseases” scheduled on September 22nd, 2022 at 12:05 PM, Mövenpick Hotel Basel (Room Ballroom).
Further information about the conference program: click here
Further information about the venue: click here